Beyond the Rash: Emerging Innovation Fuels a New Era in Dermatomyositis Therapy | Competitive Intelligence
Novel biologics & small molecules aim to disrupt dermatomyositis treatment, with late-stage pipeline therapies promising precision, and better outcomes. AUSTIN, TX, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Dermatomyositis (DM), a chronic …